Medical Devices
Adiana
BARRx
Crux Biomedical
Diomed Holdings
EKOS
Guava Technologies
Gynesonics
Light Sciences Oncology
Novasys Medical
Optiscan Biomedical
Power Medical Interventions
TransMedics
Xillix Technologies
 
Light Sciences Oncology
15405 SE 37th Street
Suite 100
Bellevue, WA 98006
425-957-8900
www.lsoncology.com
 
Light Sciences Oncology, Inc. (LSO) is developing Light Infusion Therapy (Litx(TM)) to provide safer and more effective treatment to cancer patients. In addition to the Phase III trials in hepatocellular carcinoma and colorectal cancer metastatic to the liver, the Company is conducting a Phase II clinical trial of Litx in glioma. In December 2006, LSO purchased the assets of its former parent company Light Sciences Corporation (LSC), securing all Litx intellectual property and widening its scope of potential therapeutic applications to include benign neoplasms such as benign prostatic hyperplasia (BPH) and uterine fibroids, as well as vascular disease, dermatology, and all other applications of the versatile Litx platform. The Company has positioned itself for growth with a strong portfolio of intellectual property, innovative applications in development, and an exceptionally talented team.

 
Light Sciences Oncology in the News
7/24/2008
4/7/2008